Alivus Life Sciences Ltd Peer Comparison

Alivus Life Sciences Ltd Share Price
Detail Overview
Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE
₹1,269.00
+11.10(+0.88%)
As on 22 Oct 2026 at 15:56
As of 22 Oct 2026 at 15:56, Alivus Life Sciences Ltd is trading at ₹1,269.00. The 52-week range stands at ₹819.00–₹1,493.80, with a market cap of ₹15.56 thousand crore. At a P/E of 25.03 and a dividend yield of 0.39%, it is a mid-cap stock in the Pharmaceuticals sector.

Alivus Life Sciences Ltd Peer Comparison

StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,753.95
8.85(+0.51%)
4,20,831.41,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,610.15
56.35(+1.24%)
1,75,355.33,532.6 - 5,250.0
Cipla Ltd
₹1,329.90
15.90(+1.21%)
1,07,438.7—
Dr Reddys Laboratories Ltd
₹1,239.00
-5.50(-0.44%)
1,03,416.9—
Lupin Ltd
₹1,928.00
-36.00(-1.83%)
88,165.5—

Frequently asked questions

The market capitalisation of Alivus Life Sciences Ltd is approximately ₹15,561 crore, compared with ₹4,20,831 crore for its selected peer.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now